Rajesh Pal

Mr. Rajesh Pal

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Molecules
Verified
Journal Article
Open access
PDF file
MPMaria Barbara Pisano
Maria Barbara Pisano
Amit KumarAmit Kumar
Amit Kumar
RMRosaria Medda
Rosaria Medda
GGGianluca Gatto
Gianluca Gatto
RPRajesh Pal
Rajesh Pal
MMMaria Matos
Maria Matos
Antibiotic resistance is one of the main public health concerns of this century. This resistance is also associated with oxidative stress, which could contribute to the selection of resistant bacterial strains. Bearing this in mind, and considering that flavonoid compounds are well known for displaying both activities, we investigated a series of hydroxy-3-arylcoumarins with structural features of flavonoids for their antibacterial activity against different bacterial strains. Active compounds showed selectivity against the studied Gram-positive bacteria compared to Gram-negative bacteria. 5,7-Dihydroxy-3-phenylcoumarin (compound 8) displayed the best antibacterial activity against Staphylococcus aureus and Bacillus cereus with minimum inhibitory concentrations (MICs) of 11 μg/mL, followed by Staphylococcus aureus (MRSA strain) and Listeria monocytogenes with MICs of 22 and 44 μg/mL, respectively. Moreover, molecular docking studies performed on the most active compounds against Staphylococcus aureus tyrosyl-tRNA synthetase and topoisomerase II DNA gyrase revealed the potential binding mode of the ligands to the site of the appropriate targets. Preliminary structure–activity relationship studies showed that the antibacterial activity can be modulated by the presence of the 3-phenyl ring and by the position of the hydroxyl groups at the coumarin scaffold.

1 March 2021 in Environmental Pollution
Verified
Journal Article
Closed access
VSVipendra Kumar Singh
Vipendra Kumar Singh
RPRajesh Pal
Rajesh Pal
PSPriyansh Srivastava
Priyansh Srivastava
GMGauri Misra
Gauri Misra
YSYogeshwer Shukla
Yogeshwer Shukla
PSPradeep Kumar Sharma
Pradeep Kumar Sharma

1 September 2021 in The American Journal of Pathology
Verified
Journal Article
Closed access
XLXinjun Lu
Xinjun Lu
BPBaogang Peng
Baogang Peng
GCGe Chen
Ge Chen
MPMario G. Pes
Mario G. Pes
SRSilvia Ribback
Silvia Ribback
JWJingxiao Wang
Jingxiao Wang

3 July 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FSFrancesca Sedda
Francesca Sedda
ACAndrea Caddeo
Andrea Caddeo
KSKavitha Sasidharan
Kavitha Sasidharan
GPGiovanni Perra
Giovanni Perra
RPRajesh Pal
Rajesh Pal
APAndrea Perra
Andrea Perra
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease, and liver-related morbidity and mortality worldwide. MASLD is a multifactorial condition, which still needs to be completely understood. Galectin 3 (Gal-3) is up-regulated in several liver disorders suggesting its implication in the mechanisms underlying liver damage. Methods: A human multilineage 3D model was utilized to investigate the role of Gal-3 in MASLD development. Human hepatoma cell line (HepG2) and human stellate cell line (LX-2) were co-cultured in a physiological ratio of 24:1 and treated with a mixture of palmitic and oleic acid (PAOA, ratio 1:2) to induce hepatocyte steatosis and facilitate the development of fibrosis. While the effect of LGALS3 silencing on neutral fat content was assessed by Oil-Red-O (ORO) staining, type I collagen production was analysed by immunofluorescent staining for collagen type I alpha 1 (COL1A1). Results: Gal-3 depletion caused a reduction of neutral lipid content and COL1A1 accumulation in 3D spheroids. While LGALS3 silencing did not significantly alter the respiratory state, analysis of genes involved in lipid metabolism demonstrated significant changes in genes involved in β-oxidation and triglyceride synthesis. Conclusion: These results suggest a role of Gal-3 in the regulation of fatty acid and collagen accumulation, thereby indicating that approaches aimed at inhibiting Gal-3 may represent a promising therapeutic strategy in MASLD.

17 February 2022 in Cell Proliferation
Verified
Journal Article
Open access
PDF file
RPRajesh Pal
Rajesh Pal
MKMarta Anna Kowalik
Marta Anna Kowalik
MSMarina Serra
Marina Serra
CMCristina Migliore
Cristina Migliore
SGSilvia GIORDANO
Silvia GIORDANO
APAndrea Perra
Andrea Perra
Objectives: Adult hepatocytes are quiescent cells that can be induced to proliferate in response to a reduction in liver mass (liver regeneration) or by agents endowed with mitogenic potency (primary hyperplasia). The latter condition is characterized by a more rapid entry of hepatocytes into the cell cycle, but the mechanisms responsible for the accelerated entry into the S phase are unknown.Materials and methods: Next generation sequencing and Illumina microarray were used to profile microRNA and mRNA expression in CD‐1 mice livers 1, 3 and 6 h after 2/3 partial hepatectomy (PH) or a single dose of TCPOBOP, a ligand of the constitutive androstane receptor (CAR). Ingenuity pathway and DAVID analyses were performed to identify deregulated pathways. MultiMiR analysis was used to construct microRNA‐mRNA networks.Results: Following PH or TCPOBOP we identified 810 and 527 genes, and 102 and 10 miRNAs, respectively, differentially expressed. Only 20 genes and 8 microRNAs were shared by the two conditions. Many miRNAs targeting negative regulators of cell cycle were downregulated early after PH, concomitantly with increased expression of their target genes. On the contrary, negative regulators were not modified after TCPOBOP, but Ccnd1 targeting miRNAs, such as miR‐106b‐5p, were downregulated.Conclusions: While miRNAs targeting negative regulators of the cell cycle are downregulated after PH, TCPOBOP caused downregulation of miRNAs targeting genes required for cell cycle entry. The enhanced Ccnd1 expression may explain the more rapid entry into the S phase of mouse hepatocytes following TCPOBOP.

1 January 2017
Verified
Conference Paper
Closed access
RPRajesh Pal
Rajesh Pal
GMGauri Misra
Gauri Misra
PMPuniti Mathur
Puniti Mathur
Zika virus (ZIKV) has recently infected around 2 million people around the world and presently there is no USFDA approved drug in the market. In the present study, molecular docking analysis of two essential non-structural proteins NS2B/NS3 protease and NS3 helicase, which are involved in viral replication, has been reported. Identification of potential inhibitors could be considered as a strategy for treatment of the ZIKV infection. Using structure based drug design, docking of 1, 15,203 compounds were performed for both the proteins and 10 ligands were identified for each protein, which may serve as potential inhibitors. These molecules can further be validated in experimental studies.